CHICAGO - Imagine reading a CT scan of a liver tumor and being able to easily view similar scans, diagnoses, or tumors. It’s a vision of Sandy Napel, PhD, professor of radiology at Stanford School of Medicine, who has been working with his colleagues to develop an image analysis and decision support tool.
CHICAGO - Imagine reading a CT scan of a liver tumor and being able to easily view similar scans, diagnoses, or tumors. It’s a vision of Sandy Napel, PhD, professor of radiology at Stanford School of Medicine, who has been working with his colleagues to develop an image analysis and decision support tool.
“How many times have you been looking at something and saying, ‘When was the last time I saw a liver tumor like this?’” Napel asked the audience at an RSNA session Wednesday.
His pilot system, known as the Electronic Physician Annotation Device (ePAD), characterizes images with features and semantic annotations that can be accessed by the computer for comparison to other images based on a feature vector that scores and reorders the images based on similarity. The database uses consistent radiology terms and features familiar to radiology to then input and organize the images.
For example, a radiologist can query the system based on shape of the lesion or texture, bringing up a host of similar images and information to inform the current read. The information can be used in decision support through computer-based image retrieval.
“This can be made to work and hopefully there will be a time in the near future where you will be able to look at images similar to the patient you are trying to evaluate,” he said, adding that it should be applicable in other disease and imaging scenarios. His group is now looking at how include genomic and other clinical data to images of non-small cell lung cancer to aid in diagnosis and treatment.
Such a computer-based image retrieval system will provide similar images, similar diagnoses, and even evidence-based, relevant data to help guide the radiologist in decision support. Napel added, “This will all be moved into PACS 2.0.”
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.